Featured Research

from universities, journals, and other organizations

Study finds association between blood biomarker and risk of death

Date:
September 6, 2011
Source:
JAMA and Archives Journals
Summary:
In an analysis of data from two separate study groups, elderly men and women who had higher levels of the protein biomarker cathepsin S in their blood had an increased risk of death, according to a new study. This biomarker might have a relationship with the development of cardiovascular disease and cancer.

In an analysis of data from two separate study groups, elderly men and women who had higher levels of the protein biomarker cathepsin S in their blood had an increased risk of death, according to a study in JAMA. This biomarker might have a relationship with the development of cardiovascular disease and cancer.

The study was published early online to coincide with its presentation at the European Society of Cardiology Congress.

Cathepsin S is a cysteine protease (a type of enzyme) involved in intracellular and extracellular proteolysis (division of proteins by cellular enzymes). Higher circulating levels of cathepsin S have been shown to be associated with increased inflammatory activity. "Experimental studies suggest that cathepsin S activity is involved in the development of cardiovascular disease via promotion of atherosclerotic plaques and destabilization of advanced plaques. Moreover, cathepsin S activity has been implicated in the development of cancer via stimulation of cancer cell migration and tumor angiogenesis," according to background information in the article. Based on these previous reports, the authors hypothesized that circulating levels of cathepsin S would be a marker for an increased mortality risk. There has been a lack of prospective data regarding this potential association.

Elisabeth Jobs, M.Sc., of Uppsala University, Uppsala, Sweden, and colleagues investigated the association between serum levels of cathepsin S and the risk of mortality in a community-based sample of elderly men and women. The researchers used data from two independent community-based cohorts, the Uppsala Longitudinal Study of Adult Men (ULSAM; n = 1,009; average age: 71 years; baseline period: 1991-1995; median [midpoint] follow-up: 12.6 years; end of follow-up: 2006) and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; n = 987; 50 percent women; average age: 70 years; baseline period: 2001-2004; median follow-up: 7.9 years; end of follow-up: 2010). Serum samples were used to measure cathepsin S.

In the ULSAM group, 413 participants died during follow-up. There were a total of 131 deaths due to cardiovascular disease and 148 deaths due to cancer. During follow-up with the PIVUS cohort, 100 participants died. The researchers found that in multivariable models adjusted for age, systolic blood pressure, diabetes, smoking status, body mass index, total cholesterol, high-density lipoprotein cholesterol, antihypertensive treatment, lipid-lowering treatment, and history of cardiovascular disease, higher serum cathepsin S was associated with an increased risk for death.

In the PIVUS cohort, participants with the highest levels of serum cathepsin S had about double (200 percent) the risk of death compared to participants with the lowest levels. The authors also found that in the ULSAM cohort, participants with the highest levels of the biomarker had an approximately 1.6 times (60 percent) increased risk for cardiovascular mortality, and an increased risk for death from cancer.

"Our community-based data confirm and extend previous experimental research that suggest that cathepsin S activity is involved in the pathological processes leading to cardiovascular disease, cancer, and death," the researchers write.

"Given its putative role in atherogenesis and tumorigenesis, cathepsin S has been put forward as a possible target of pharmaceutical intervention and the development of selective cathepsin S inhibitors is ongoing. Some of these inhibitors are being evaluated in various phases of clinical trials. If these drugs are found to be effective, tools for identification of target groups and monitoring of treatment need to be developed. Our study suggests that it is possible to assess serum levels of cathepsin S in large populations. Future intervention trials are needed to evaluate whether cathepsin S inhibition is a safe and effective pharmacological target for these diseases."

The authors add that "further research is needed to determine the utility of cathepsin S measurements in clinical settings."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. Jobs, E. Ingelsson, U. Riserus, E. Nerpin, M. Jobs, J. Sundstrom, S. Basu, A. Larsson, L. Lind, J. Arnlov. Association Between Serum Cathepsin S and Mortality in Older Adults. JAMA: The Journal of the American Medical Association, 2011; DOI: 10.1001/jama.2011.1246

Cite This Page:

JAMA and Archives Journals. "Study finds association between blood biomarker and risk of death." ScienceDaily. ScienceDaily, 6 September 2011. <www.sciencedaily.com/releases/2011/09/110906181653.htm>.
JAMA and Archives Journals. (2011, September 6). Study finds association between blood biomarker and risk of death. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2011/09/110906181653.htm
JAMA and Archives Journals. "Study finds association between blood biomarker and risk of death." ScienceDaily. www.sciencedaily.com/releases/2011/09/110906181653.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins